DDInter940 DDInter1082
Insulin lispro is a rapid-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is released from the pancreas following a meal to promote the uptake of glucose from the blood into internal organs and tissues such as the liver, fat cells, and skeletal muscle. Absorption of glucose into cells allows for its transformation into glycogen or fat for storage. Insulin also inhibits hepatic glucose production, enhances protein synthesis, and inhibits lipolysis and proteolysis among many other functions. Insulin is an important treatment in the management of Type 1 Diabetes (T1D) which is caused by an autoimmune reaction that destroys the beta cells of the pancreas, resulting in the body not being able to
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Insulin lispro {u} may cause a minor interaction that can limit clinical effects when taken with {v} Monopotassium phosphate
Insulin lispro {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Captopril
Insulin lispro {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Thyrotropin alfa
Insulin lispro {u} may lead to a major life threatening interaction when taken with {v} Cinoxacin
Insulin lispro may cause a minor interaction that can limit clinical effects when taken with Monopotassium phosphate
Insulin lispro may cause a moderate interaction that could exacerbate diseases when taken with Captopril
Insulin lispro may cause a moderate interaction that could exacerbate diseases when taken with Thyrotropin alfa
Insulin lispro may lead to a major life threatening interaction when taken with Cinoxacin